Clinical Trial Update: Irinotecan in Treating Patients With Colorectal Cancer

View source ↗

Summary

A clinical trial evaluating irinotecan for colorectal cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Camptosar (irinotecan)

Snippet

Sponsor: California Cancer Consortium | Conditions: Colorectal Cancer | Status: TERMINATED